Suchergebnisse - "Taub, Jeffrey W"

PubPharm (9)

1

The paradox of Myeloid Leukemia associated with Down syndrome

enthalten in: Biochemical pharmacology | 2022

von Gupte, A. | Al-Antary, E. | Edwards, H. | +3

2

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

enthalten in: Annals of hematology | 2021

von Gadgeel, M. | AlQanber, B. | Buck, S. | +3

3

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

enthalten in: Annals of hematology | 2021

von Gadgeel, M. | AlQanber, B. | Buck, S. | +3

4

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

enthalten in: Annals of hematology | 2021

von Gadgeel, M. | AlQanber, B. | Buck, S. | +3

5

Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis

enthalten in: Annals of hematology | 2021

von Gadgeel, M. | AlQanber, B. | Buck, S. | +3

6

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome

enthalten in: Cancer cell | 2019

von Labuhn, M. | Perkins, K. | Matzk, S. | +31

CommentIn: Cancer Cell. 2019 Aug 12;36(2):115-117. - PMID 31408616

7

Down syndrome preleukemia and leukemia

enthalten in: Pediatric clinics of North America | 2015

von Maloney, K. | Taub, J. | Ravindranath, Y. | +2

8

Prognosis and management of acute myeloid leukemia in patients with Down syndrome

enthalten in: Expert review of hematology | 2014

von Caldwell, J. | Ge, Y. | Taub, J.

9

Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia

enthalten in: Pediatric blood & cancer | 2014

von Caldwell, J. | Edwards, H. | Buck, S. | +2

1
[1]